MEP1B
MEP1B (meprin A subunit beta) is a zinc metalloprotease of the astacin group that sheds many membrane-bound proteins and degrades extracellular matrix components. It forms the beta subunit of meprin A, and was previously named meprin A, beta. Browse Assay Genie's current range of MEP1B research reagents below, or read on for the biology behind the target.
MEP1B is a membrane metallopeptidase that sheds many membrane-bound proteins. It shows a strong preference for acidic amino acids at the P1' position. Reported substrates include FGF19, VGFA, IL1B, IL18, procollagen I and III, E-cadherin, KLK7, gastrin, ADAM10 and tenascin-C. Because several pro-inflammatory cytokines are among these substrates, MEP1B has been implicated in inflammation. Its capacity to degrade extracellular matrix components also links it to tissue remodelling. It also cleaves the amyloid precursor protein (APP), releasing neurotoxic amyloid beta peptides.
Meprins are multidomain zinc metalloproteases that are highly expressed in mammalian kidney and intestinal brush border membranes, and in leukocytes and certain cancer cells. Mature meprins are oligomers of evolutionarily related but separately encoded alpha and/or beta subunits. Homooligomers of the alpha subunit (MEP1A) are secreted, whereas oligomers containing the beta subunit are plasma membrane-bound. The MEP1B gene encodes the beta subunit, and the protein is annotated at the cell membrane and as a secreted form. HGNC places it in the astacin gene group.
Meprins hydrolyse a variety of peptide and protein substrates and have been implicated in cancer and intestinal inflammation. In mice, targeted disruption of the Mep1b gene affects embryonic viability, renal gene expression profiles, and the distribution of the membrane-associated alpha subunit in kidney and intestine. Mouse and rat both carry a Mep1b ortholog.
Cytokines such as IL1B and IL18 are MEP1B substrates, which implicates the protease in inflammatory processes, including intestinal inflammation.
MEP1B cleaves amyloid precursor protein and releases neurotoxic amyloid beta peptides, making it relevant to studies of amyloid generation.
MEP1B degrades extracellular matrix components, including procollagen I and III and tenascin-C, linking it to tissue remodelling.
Meprins are highly expressed in kidney and intestinal brush border membranes, leukocytes and certain cancer cells, and have been implicated in cancer.
MEP1B is a membrane metallopeptidase that sheds many membrane-bound proteins, preferring acidic residues at the P1' position. Its substrates include IL1B, IL18, E-cadherin, procollagens and APP, so it contributes to inflammation, extracellular matrix degradation and release of amyloid beta peptides.
Mature meprins are oligomers of separately encoded alpha and/or beta subunits. MEP1B encodes the beta subunit, previously named meprin A, beta. Oligomers containing it are plasma membrane-bound, whereas alpha subunit homooligomers (MEP1A) are secreted.
Mouse and rat both have a Mep1b ortholog. Targeted disruption of the gene in mice affects embryonic viability, renal gene expression profiles and the distribution of the membrane-associated alpha subunit in kidney and intestine. Check the datasheet of any product for its validated reactivity.
The alpha subunit partner of meprin A and other related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q16820; product specifications from Assay Genie datasheets.